Trials / Active Not Recruiting
Active Not RecruitingNCT05127551
Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor
A Prospective, Randomized, Controlled, Comparitive Multicenter Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite® vs Competitor in Adult Subjects With Primary Open-Angle Glaucoma (POAG)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 179 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A study of the iStent Infinite product in the treatment of open-angle glaucoma vs competitor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iStent Infinite | Implantation of the iStent Infinite |
| DEVICE | Competitor Device | Implantation of competitor device |
Timeline
- Start date
- 2021-11-27
- Primary completion
- 2024-02-29
- Completion
- 2025-02-28
- First posted
- 2021-11-19
- Last updated
- 2024-08-15
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05127551. Inclusion in this directory is not an endorsement.